Anthera Pharmaceuticals Inc 3 SEC Filings

Filed On	Filing
12 Sep 2018	Form 3: McManigle Mark Drew, Director No securities owned
16 Aug 2016	Form 3: Shanahan William R Jr, Chief Medical Officer
29 Apr 2016	Form 3: Furse Brent, Director
05 Apr 2016	Form 3: Pennington James, Interim Chief Medical Officer Holds 17,688 shares of Common Stock
13 Jan 2016	Form 3: Olson Charles V, CHIEF TECHNOLOGY OFFICER Holds 7,963 shares of Common Stock
08 Jan 2016	Form 3: Thompson John Craig, President & COO
02 Jun 2015	Form 3: Dickinson Klara, SVP & Chief Regulatory Officer
03 Feb 2015	Form 3: Zenyaku Kogyo Co., Ltd., 10% owner Holds 2,795,895 shares of Common Stock
23 Jun 2014	Form 3: Mueller Brian, Director No securities owned
16 Jun 2014	Form 3: Sager Philip, Director No securities owned
23 Apr 2014	Form 3: Engle Steven B, Director No securities owned
28 May 2013	Form 3: Liu May, Chief Accounting Officer Holds 34,330 shares of Common Stock
03 Apr 2013	Form 3: Zweifach Sanford S, Director No securities owned
08 Mar 2012	Form 3: Dziurzynski Bogdan, Director No securities owned
10 Feb 2011	Form 3: Thompson Peter A., Director No securities owned
04 Oct 2010	Form 3: Orbimed Advisors Llc, 10% owner and 2 others Holds 3,429,834 shares of Common Stock
26 Mar 2010	Form 3: Kilfoil Georgina, SVP, Prod. Dev. & Project Mngm Holds 70,093 shares of Common Stock
23 Feb 2010	Form 3: Sofinnova Venture Partners Vi L P, 10% owner and 1 other
23 Feb 2010	Form 3: Healy James, Director Holds 20,443 shares of Common Stock
23 Feb 2010	Form 3: Leheny A. Rachel, Director

Comments